FI20106121A - Soluviljelymateriaali - Google Patents

Soluviljelymateriaali Download PDF

Info

Publication number
FI20106121A
FI20106121A FI20106121A FI20106121A FI20106121A FI 20106121 A FI20106121 A FI 20106121A FI 20106121 A FI20106121 A FI 20106121A FI 20106121 A FI20106121 A FI 20106121A FI 20106121 A FI20106121 A FI 20106121A
Authority
FI
Finland
Prior art keywords
cell culture
culture materials
materials
cellulose nanofibers
compositions
Prior art date
Application number
FI20106121A
Other languages
English (en)
Swedish (sv)
Other versions
FI20106121A0 (fi
FI20106121L (fi
FI123988B (fi
Inventor
Marjo Yliperttula
Patrick Lauren
Madhushree Bhattacharya
Yanru Lou
Antti Laukkanen
Original Assignee
Upm Kymmene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upm Kymmene Corp filed Critical Upm Kymmene Corp
Publication of FI20106121A0 publication Critical patent/FI20106121A0/fi
Priority to FI20106121A priority Critical patent/FI123988B/fi
Priority to US13/881,959 priority patent/US10612003B2/en
Priority to RU2013122757/10A priority patent/RU2597978C2/ru
Priority to US13/881,973 priority patent/US20140010790A1/en
Priority to BR112013010377-9A priority patent/BR112013010377B1/pt
Priority to PL15155375T priority patent/PL2975115T3/pl
Priority to EP15155375.7A priority patent/EP2975115B1/en
Priority to DK11785713.6T priority patent/DK2633032T3/en
Priority to PL11785713T priority patent/PL2633032T3/pl
Priority to AU2011322363A priority patent/AU2011322363B2/en
Priority to EP11785715.1A priority patent/EP2632493B1/en
Priority to PCT/FI2011/050941 priority patent/WO2012056111A2/en
Priority to PCT/FI2011/050940 priority patent/WO2012056110A2/en
Priority to JP2013535476A priority patent/JP6321961B2/ja
Priority to ES11785713.6T priority patent/ES2537268T3/es
Priority to US13/881,982 priority patent/US9631177B2/en
Priority to PCT/FI2011/050939 priority patent/WO2012056109A2/en
Priority to DK15155375T priority patent/DK2975115T3/da
Priority to CN2011800627192A priority patent/CN103354834A/zh
Priority to ES11785715.1T priority patent/ES2565958T3/es
Priority to CN201710872909.XA priority patent/CN107557330B/zh
Priority to JP2013535475A priority patent/JP2013541956A/ja
Priority to SG2013030721A priority patent/SG189966A1/en
Priority to EP11785713.6A priority patent/EP2633032B1/en
Priority to DK11785715.1T priority patent/DK2632493T3/da
Priority to EP11785714.4A priority patent/EP2633033B1/en
Priority to CA2815276A priority patent/CA2815276C/en
Priority to ES15155375T priority patent/ES2759257T3/es
Publication of FI20106121L publication Critical patent/FI20106121L/fi
Publication of FI20106121A publication Critical patent/FI20106121A/fi
Priority to IL225923A priority patent/IL225923B/en
Application granted granted Critical
Publication of FI123988B publication Critical patent/FI123988B/fi
Priority to HK14101542.5A priority patent/HK1188466A1/xx
Priority to JP2017241022A priority patent/JP6448755B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3637—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L97/00—Compositions of lignin-containing materials
    • C08L97/02—Lignocellulosic material, e.g. wood, straw or bagasse
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/22—Processes using, or culture media containing, cellulose or hydrolysates thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • C12N11/12—Cellulose or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/78—Cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
FI20106121A 2010-10-27 2010-10-27 Soluviljelymateriaali FI123988B (fi)

Priority Applications (31)

Application Number Priority Date Filing Date Title
FI20106121A FI123988B (fi) 2010-10-27 2010-10-27 Soluviljelymateriaali
PCT/FI2011/050939 WO2012056109A2 (en) 2010-10-27 2011-10-26 Plant derived cell culture material
CN2011800627192A CN103354834A (zh) 2010-10-27 2011-10-26 植物来源细胞培养材料
US13/881,973 US20140010790A1 (en) 2010-10-27 2011-10-26 Cell culture material based on microbial cellulose
BR112013010377-9A BR112013010377B1 (pt) 2010-10-27 2011-10-26 composição fornecedora de células ou de cultura de células, matriz fornecedora de células ou de cultura de células, métodos para produzir uma composição, para remover nanofibras de celulose e para cultura de células, uso microbiológico de nanofibras, e, uso da composição
DK15155375T DK2975115T3 (da) 2010-10-27 2011-10-26 Planteafledt cellekulturmateriale
EP15155375.7A EP2975115B1 (en) 2010-10-27 2011-10-26 Plant derived cell culture material
DK11785713.6T DK2633032T3 (en) 2010-10-27 2011-10-26 Plant-derived cell culture material
RU2013122757/10A RU2597978C2 (ru) 2010-10-27 2011-10-26 Материал для культур клеток, полученный из растений
AU2011322363A AU2011322363B2 (en) 2010-10-27 2011-10-26 Plant derived cell culture material
ES11785715.1T ES2565958T3 (es) 2010-10-27 2011-10-26 Composiciones de suministro de fármaco
PCT/FI2011/050941 WO2012056111A2 (en) 2010-10-27 2011-10-26 Drug delivery compositions
PCT/FI2011/050940 WO2012056110A2 (en) 2010-10-27 2011-10-26 Cell culture material based on microbial cellulose
JP2013535476A JP6321961B2 (ja) 2010-10-27 2011-10-26 薬剤送達組成物
ES11785713.6T ES2537268T3 (es) 2010-10-27 2011-10-26 Material de cultivo celular derivado de plantas
US13/881,982 US9631177B2 (en) 2010-10-27 2011-10-26 Drug delivery compositions
US13/881,959 US10612003B2 (en) 2010-10-27 2011-10-26 Plant derived cell culture material
PL15155375T PL2975115T3 (pl) 2010-10-27 2011-10-26 Materiał pochodzenia roślinnego do hodowli komórek
PL11785713T PL2633032T3 (pl) 2010-10-27 2011-10-26 Materiał pochodzenia roślinnego do hodowli komórek
EP11785715.1A EP2632493B1 (en) 2010-10-27 2011-10-26 Drug delivery compositions
CN201710872909.XA CN107557330B (zh) 2010-10-27 2011-10-26 植物来源细胞培养材料
JP2013535475A JP2013541956A (ja) 2010-10-27 2011-10-26 植物由来の細胞培養材料
SG2013030721A SG189966A1 (en) 2010-10-27 2011-10-26 Plant derived cell culture material
EP11785713.6A EP2633032B1 (en) 2010-10-27 2011-10-26 Plant derived cell culture material
DK11785715.1T DK2632493T3 (da) 2010-10-27 2011-10-26 Lægemiddelindgivelsessammensætninger
EP11785714.4A EP2633033B1 (en) 2010-10-27 2011-10-26 Cell culture material based on microbial cellulose
CA2815276A CA2815276C (en) 2010-10-27 2011-10-26 Plant derived cell culture material
ES15155375T ES2759257T3 (es) 2010-10-27 2011-10-26 Material de cultivo celular derivado de plantas
IL225923A IL225923B (en) 2010-10-27 2013-04-24 Cell culture material derived from a plant, methods for its preparation and uses thereof
HK14101542.5A HK1188466A1 (en) 2010-10-27 2014-02-19 Plant derived cell culture material
JP2017241022A JP6448755B2 (ja) 2010-10-27 2017-12-15 植物由来の細胞培養材料

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20106121A FI123988B (fi) 2010-10-27 2010-10-27 Soluviljelymateriaali
FI20106121 2010-10-27

Publications (4)

Publication Number Publication Date
FI20106121A0 FI20106121A0 (fi) 2010-10-27
FI20106121L FI20106121L (fi) 2012-04-28
FI20106121A true FI20106121A (fi) 2012-04-28
FI123988B FI123988B (fi) 2014-01-31

Family

ID=43064279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20106121A FI123988B (fi) 2010-10-27 2010-10-27 Soluviljelymateriaali

Country Status (16)

Country Link
US (3) US10612003B2 (fi)
EP (4) EP2633033B1 (fi)
JP (3) JP2013541956A (fi)
CN (2) CN107557330B (fi)
AU (1) AU2011322363B2 (fi)
BR (1) BR112013010377B1 (fi)
CA (1) CA2815276C (fi)
DK (3) DK2632493T3 (fi)
ES (3) ES2537268T3 (fi)
FI (1) FI123988B (fi)
HK (1) HK1188466A1 (fi)
IL (1) IL225923B (fi)
PL (2) PL2975115T3 (fi)
RU (1) RU2597978C2 (fi)
SG (1) SG189966A1 (fi)
WO (3) WO2012056111A2 (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389537B2 (en) 2011-11-15 2022-07-19 Upm-Kymmene Corporation Drug delivery system for sustained delivery of bioactive agents

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI123988B (fi) 2010-10-27 2014-01-31 Upm Kymmene Corp Soluviljelymateriaali
FI123715B (fi) * 2011-12-22 2013-09-30 Upm Kymmene Corp Koostumus sulautettuun mikrobiviljelyyn
FI123694B (fi) * 2011-12-22 2013-09-30 Upm Kymmene Corp Matriisi ja koostumus grampositiivisten bakteerien mikrobiviljelyyn
FI126055B (fi) * 2012-05-14 2016-06-15 Upm Kymmene Corp Menetelmä kalvon valmistamiseksi fibrillisellusta ja fibrillisellukalvo
FI125965B (fi) * 2012-09-25 2016-04-29 Upm Kymmene Corp Kolmiulotteinen soluviljely
JP5846449B2 (ja) * 2012-11-12 2016-01-20 北越紀州製紙株式会社 電池用セパレータの製造方法及び電池用セパレータ
CN102978256B (zh) * 2012-12-26 2013-11-20 东华大学 一种连续生产细菌纤维素的方法
FI126109B (fi) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibrillipolysakkaridi käytettäväksi kuroutumisen ja arpeutumisen hallitsemiseen ja estoon
CA2918289A1 (en) 2013-07-18 2015-01-22 The Governors Of The University Of Alberta Parallel organic synthesis on patterned paper using a solvent-repelling material
CN103422379B (zh) * 2013-08-19 2016-03-30 南京林业大学 一种甘蔗渣纤维素纳米纤维膜的制备方法
FI126854B (fi) * 2013-12-30 2017-06-30 Upm Kymmene Corp Membraani, sen käyttö ja menetelmä membraanin valmistusta varten
EP3098300B1 (en) * 2014-01-23 2020-06-24 Nissan Chemical Corporation Culture medium composition
EP3098306A4 (en) * 2014-01-23 2017-07-26 Nissan Chemical Industries, Ltd. Undifferentiated maintenance culture material
JP6369044B2 (ja) * 2014-02-19 2018-08-08 凸版印刷株式会社 培養装置およびその製造方法
JP2015159778A (ja) * 2014-02-28 2015-09-07 日本バイリーン株式会社 光学的測定用細胞培養担体、光学的測定用ウェルプレート、及び細胞の光学的測定方法
WO2015136370A2 (en) * 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
KR102440051B1 (ko) * 2014-03-21 2022-09-06 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 세포외 기질로부터 유래한 최종 멸균된 하이드로겔의 제조 방법
JP5727657B1 (ja) * 2014-09-22 2015-06-03 第一工業製薬株式会社 セルロースナノファイバー分散体の製造方法。
EP3011952A1 (en) * 2014-10-24 2016-04-27 Centre National De La Recherche Scientifique -Cnrs- Time-controlled glucose releasing hydrogels and applications thereof
EP3233493B1 (en) 2014-12-18 2021-06-16 Cellink Ab Cellulose nanofibrillar bioink for 3d bioprinting for cell culturing, tissue engineering and regenerative medicine applications
FI126398B (fi) 2014-12-18 2016-11-15 Upm Kymmene Corp Menetelmä kemikaalitestausta varten
FI126120B (fi) * 2014-12-22 2016-06-30 Upm Kymmene Corp Prosessi hapetetun nanofibrilliselluloosan hydrogeelin tuottamiseksi
FI125884B2 (fi) 2014-12-22 2019-03-29 Upm Kymmene Corp Nanofibrilliselluloosan hydrogeelin käsittely korkeassa lämpötilassa
FI125758B (fi) * 2014-12-22 2016-02-15 Upm Kymmene Corp Menetelmä nanofibrilliselluloosan hydrogeelin viskositeetin vähentämiseksi
FI125883B (fi) 2014-12-22 2016-03-31 Upm Kymmene Corp Katalyyttisesti hapetetun nanofibrilliselluloosan hydrogeelin käsittely
WO2016146616A1 (en) 2015-03-16 2016-09-22 Ventana Medical Systems, Inc. Control slides for immunohistochemistry generated from three-dimensional cell line cultures
US11390835B2 (en) * 2015-05-08 2022-07-19 University Of Florida Research Foundation, Inc. Growth media for three-dimensional cell culture
FI127834B (fi) 2015-06-04 2019-03-29 Upm Kymmene Corp Prosessi nanofibrilliselluloosan hydrogeelin tuottamiseksi
EP3344236A4 (en) * 2015-08-31 2019-05-08 Cormedix Inc. ADMINISTERING ACTIVE AGENTS USING A NANOFIBER BAND
CN108604441A (zh) * 2015-12-30 2018-09-28 瑞士材料试验研究所 改善云杉共振木材的声学特性的方法
EP3232432A1 (de) * 2016-04-11 2017-10-18 EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt Verfahren zur verbesserung der akustischen eigenschaften von fichten-klangholz
JP2017127264A (ja) * 2016-01-21 2017-07-27 株式会社スギノマシン アスペルギルス・オリゼ由来のホルムアルデヒド分解酵素およびホルムアルデヒド分解酵素を用いたホルムアルデヒドの分解方法
JP2017189164A (ja) * 2016-04-08 2017-10-19 三菱ケミカル株式会社 細胞及び／又は細胞外マトリックス成分を含む組成物
WO2017199737A1 (ja) * 2016-05-16 2017-11-23 富士フイルム株式会社 培養細胞の回収方法および培養細胞分散液
US20190209738A1 (en) * 2016-06-09 2019-07-11 Paul Gatenholm Preparation and applications of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks to control cellular fate processes such as adhesion, proliferation and differentiation
JP6758621B2 (ja) * 2016-10-17 2020-09-23 株式会社日本触媒 細胞培養用基材およびその製造方法、ならびにこれを利用した細胞培養容器および細胞培養方法
JP6874329B2 (ja) * 2016-11-01 2021-05-19 凸版印刷株式会社 ホルムアルデヒド除去組成物およびその製造方法、ホルムアルデヒド除去シート
CN106544281B (zh) * 2016-12-07 2019-07-02 哈尔滨工业大学 一种基于蛋白质和多糖构筑生物体保护层的制备方法
EP3335740A1 (en) * 2016-12-15 2018-06-20 UPM-Kymmene Corporation Medical hydrogel
DE102017000368A1 (de) 2017-01-16 2018-07-19 Gabriele Blume Einbringen von schwer und/oder nicht wasserlöslichen Wirkstoffen mittels auf Lipiden basierenden Nanopartikeln/Vesikeln in ein hydrophiles aus Cellulose bestehendes dreidimensionales Netzwerk.
KR20190137119A (ko) * 2017-03-30 2019-12-10 닛산 가가쿠 가부시키가이샤 나노섬유를 이용한 세포 배양
SG11201909419XA (en) 2017-04-10 2019-11-28 TheWell Bioscience Hydrogel for cell culture and biomedical applications
EP3418377B1 (en) 2017-06-22 2024-04-17 UPM-Kymmene Corporation Supportive nanofibrillar cellulose scaffold for expanding cells
JP7132566B2 (ja) * 2017-09-04 2022-09-07 学校法人早稲田大学 チキソトロピー性を有するゲルを用いる多層３次元細胞培養足場システム
JP7349156B2 (ja) * 2017-12-21 2023-09-22 エイチ アンド エー ファーマケム カンパニー，リミテッド 金属有機構造体及びナノセルロースを用いた経皮送達用複合体
CN108300713A (zh) * 2017-12-31 2018-07-20 宁波大学 固定细胞的方法及装置
US11931966B2 (en) 2018-01-26 2024-03-19 Cellink Bioprinting Ab Systems and methods for optical assessments of bioink printability
EP3533458B1 (en) * 2018-03-02 2023-05-03 UPM-Kymmene Corporation A medical product comprising a bioactive molecule immobilized to nanofibrillar cellulose, and a method for preparing thereof
WO2019181294A1 (ja) * 2018-03-23 2019-09-26 国立研究開発法人物質・材料研究機構 スルホン化セルロースナノファイバーを含むハイドロゲル
EP3581591A1 (en) * 2018-06-13 2019-12-18 UPM-Kymmene Corporation A nanofibrillar cellulose product and a method for manufacturing thereof
EP3616730A1 (en) 2018-08-28 2020-03-04 UPM-Kymmene Corporation Composition or matrix for storage of bacteriophages comprising nanofibrillar cellulose
WO2020077118A1 (en) 2018-10-10 2020-04-16 Cellink Ab Double network bioinks
KR20220046512A (ko) * 2019-04-22 2022-04-14 이엘씨 매니지먼트 엘엘씨 셀룰로오스 나노섬유를 함유하는 국소 전달 시스템
EP3750982A1 (en) * 2019-06-10 2020-12-16 UPM-Kymmene Corporation Cell culture plate, method for preparing thereof and method for detecting a substance
HUP1900226A1 (hu) * 2019-06-21 2020-12-28 Hummel Zoltan Dr Hidrofil mikrobiális cellulóz nanorostokat tartalmazó hordozóanyag (gél) a bélnyálkahártya állapotának javítására
WO2020260741A1 (en) * 2019-06-24 2020-12-30 Upm-Kymmene Corporation Transplantable cell composition comprising eukaryotic cells in a nanofibrillar cellulose hydrogel, method for preparing thereof and use of nanofibrillar cellulose
CN110387060B (zh) * 2019-07-15 2021-10-29 陕西科技大学 一种用于细胞培养的水下透明多孔纤维素纸基材料及其制备方法和应用
EP3771470A1 (en) * 2019-07-29 2021-02-03 UPM-Kymmene Corporation Medical hydrogel comprising nanofibrillar cellulose, tailored wound dressing, and methods for preparing thereof
US11826951B2 (en) 2019-09-06 2023-11-28 Cellink Ab Temperature-controlled multi-material overprinting
EP3791864A1 (en) 2019-09-13 2021-03-17 UPM-Kymmene Corporation Method for preparing pharmaceutical composition and pharmaceutical composition
EP3791858A1 (en) * 2019-09-13 2021-03-17 UPM-Kymmene Corporation Injectable pharmaceutical formulation
US11131059B2 (en) * 2019-11-15 2021-09-28 Innovatech Engineering Llc Nanocellulose composite sheet for use as dermatological treatment or medical device
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US20220295861A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US20210170031A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
GB2592240B (en) 2020-02-21 2022-03-23 Advanced Biofuel Solutions Ltd Waste processing system
JP2021136912A (ja) * 2020-03-04 2021-09-16 国立大学法人東海国立大学機構 細胞の機能を変化させる方法
WO2022023815A1 (en) 2020-07-31 2022-02-03 Ocean Tunicell As Biocompatible, injectable and in situ gelling hydrogels and preparation and applications of biocompatible, injectable and in situ gelling hydrogels based on cellulose nanofibrils for tissue and organ repair
CN112138215B (zh) * 2020-09-26 2021-11-05 江苏大学 基于纳米纤维素的细胞生长因子缓释各向异性支架构建方法和应用
WO2023028664A1 (en) * 2021-09-02 2023-03-09 The University Of Queensland Injectable composition

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3783073T2 (de) 1986-04-22 1993-04-29 Ajinomoto Kk Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen.
US5254471A (en) 1986-10-06 1993-10-19 Toray Industries, Inc. Carrier for cell culture
US5405953A (en) 1993-08-03 1995-04-11 Biocontrol Incorporated Microfibrillated oxycellulose
US6602994B1 (en) 1999-02-10 2003-08-05 Hercules Incorporated Derivatized microfibrillar polysaccharide
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
AU2003274900A1 (en) 2002-07-15 2004-02-02 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
US20050037082A1 (en) 2003-08-13 2005-02-17 Wan-Kei Wan Poly(vinyl alcohol)-bacterial cellulose nanocomposite
US20080146701A1 (en) 2003-10-22 2008-06-19 Sain Mohini M Manufacturing process of cellulose nanofibers from renewable feed stocks
US7704740B2 (en) 2003-11-05 2010-04-27 Michigan State University Nanofibrillar structure and applications including cell and tissue culture
WO2007012050A2 (en) 2005-07-20 2007-01-25 Surmodics, Inc. Polymer coated nanofibrillar structures and methods for cell maintenance and differentiation
CN100531685C (zh) 2005-07-20 2009-08-26 同济大学 一种组织工程血管及其体外构建方法
CN100355975C (zh) * 2005-08-19 2007-12-19 清华大学 一种天然纳米纤维的制备方法
US8951551B2 (en) * 2005-08-31 2015-02-10 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
CN101356222B (zh) 2005-12-06 2013-11-20 Fmc公司 纤维素凝胶制剂
US20070275458A1 (en) 2005-12-09 2007-11-29 The Research Foundation Of State University Of New York Three dimensional-BIO-mimicking active scaffolds
EP2021283B1 (en) 2006-05-04 2015-07-08 Agency for Science, Technology and Research Mechanically reversible gel
JP4998981B2 (ja) * 2006-06-20 2012-08-15 国立大学法人 東京大学 微細セルロース繊維
US20080193536A1 (en) * 2006-08-14 2008-08-14 Alireza Khademhosseini Cell-Laden Hydrogels
JP5030667B2 (ja) 2007-05-29 2012-09-19 国立大学法人京都大学 ミクロフィブリル化セルロース複合樹脂及びその製造方法
JP2008308802A (ja) 2007-06-18 2008-12-25 Univ Of Tokyo セルロースナノファイバーの製造方法
US8834917B2 (en) * 2007-11-13 2014-09-16 Jawaharlal Nehru Centre For Advanced Scientific Research Nanoparticle composition and process thereof
WO2009095562A2 (fr) 2007-11-14 2009-08-06 Ma.I.A Woundcare Biomateriau permettant la delivrance controlee d'actifs
JP5260033B2 (ja) * 2007-11-27 2013-08-14 花王株式会社 食後ｇｉｐ及び／又は食後インスリン分泌抑制剤
DE102008014735A1 (de) * 2008-03-18 2009-09-24 Studiengesellschaft Kohle Mbh Verfahren zur Depolymerisation von Zellulose
SE0800807L (sv) * 2008-04-10 2009-10-11 Stfi Packforsk Ab Nytt förfarande
AT506657A1 (de) 2008-04-14 2009-10-15 Chemiefaser Lenzing Ag Cellulosebasiertes hydrogel und verfahren zu seiner herstellung
JP5386866B2 (ja) * 2008-06-30 2014-01-15 国立大学法人京都大学 ナノファイバーシート
JP2010013604A (ja) * 2008-07-07 2010-01-21 Toray Ind Inc セルロース分散体
US20100065236A1 (en) * 2008-09-17 2010-03-18 Marielle Henriksson Method of producing and the use of microfibrillated paper
WO2010039865A2 (en) 2008-10-01 2010-04-08 Cornell University Biodegradable chemical delivery system
US20110198282A1 (en) 2008-10-07 2011-08-18 The Research Foundation Of State University Of New York High flux high efficiency nanofiber membranes and methods of production thereof
CN101392246A (zh) 2008-10-29 2009-03-25 东北电力大学 一种利用细菌纤维素膜做载体固定化白腐真菌的方法
WO2010065908A2 (en) 2008-12-05 2010-06-10 Catchmark Jeffrey M Degradable biomolecule compositions
FI124724B (fi) 2009-02-13 2014-12-31 Upm Kymmene Oyj Menetelmä muokatun selluloosan valmistamiseksi
US9192655B2 (en) * 2009-03-12 2015-11-24 New Jersey Institute Of Technology System and method for a hydrogel and hydrogel composite for cartilage repair applications
EP2805986B1 (en) * 2009-03-30 2017-11-08 FiberLean Technologies Limited Process for the production of nano-fibrillar cellulose gels
JP5243371B2 (ja) * 2009-09-07 2013-07-24 第一工業製薬株式会社 ゲル状組成物
US8940337B2 (en) * 2009-12-30 2015-01-27 Axcelon Biopolymers Corporation Transparent bacterial cellulose nanocomposite hydrogels
FI123988B (fi) 2010-10-27 2014-01-31 Upm Kymmene Corp Soluviljelymateriaali

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389537B2 (en) 2011-11-15 2022-07-19 Upm-Kymmene Corporation Drug delivery system for sustained delivery of bioactive agents

Also Published As

Publication number Publication date
EP2633033A2 (en) 2013-09-04
CN107557330A (zh) 2018-01-09
WO2012056109A3 (en) 2012-06-28
IL225923B (en) 2018-01-31
FI20106121A0 (fi) 2010-10-27
WO2012056111A2 (en) 2012-05-03
BR112013010377B1 (pt) 2021-01-19
DK2975115T3 (da) 2019-11-04
PL2633032T3 (pl) 2015-08-31
WO2012056110A3 (en) 2012-06-14
US10612003B2 (en) 2020-04-07
IL225923A0 (en) 2013-06-27
JP2018102291A (ja) 2018-07-05
EP2633033B1 (en) 2016-04-06
HK1188466A1 (en) 2014-05-02
WO2012056110A2 (en) 2012-05-03
BR112013010377A2 (pt) 2016-07-05
DK2633032T3 (en) 2015-05-04
US20140010790A1 (en) 2014-01-09
JP6321961B2 (ja) 2018-05-09
EP2632493A2 (en) 2013-09-04
EP2632493B1 (en) 2015-12-30
ES2537268T3 (es) 2015-06-05
FI20106121L (fi) 2012-04-28
CN107557330B (zh) 2022-09-13
FI123988B (fi) 2014-01-31
RU2013122757A (ru) 2014-12-10
EP2975115A1 (en) 2016-01-20
JP6448755B2 (ja) 2019-01-09
EP2633032B1 (en) 2015-02-25
AU2011322363A1 (en) 2013-06-13
CA2815276A1 (en) 2012-05-03
US20130330379A1 (en) 2013-12-12
PL2975115T3 (pl) 2020-05-18
JP2013540804A (ja) 2013-11-07
WO2012056111A3 (en) 2012-06-14
SG189966A1 (en) 2013-06-28
CA2815276C (en) 2019-09-10
DK2632493T3 (da) 2016-03-14
EP2633032A2 (en) 2013-09-04
ES2565958T3 (es) 2016-04-07
ES2759257T3 (es) 2020-05-08
JP2013541956A (ja) 2013-11-21
RU2597978C2 (ru) 2016-09-20
US9631177B2 (en) 2017-04-25
US20130344036A1 (en) 2013-12-26
WO2012056109A2 (en) 2012-05-03
EP2975115B1 (en) 2019-09-11
CN103354834A (zh) 2013-10-16
AU2011322363B2 (en) 2015-07-09

Similar Documents

Publication Publication Date Title
FI20106121A (fi) Soluviljelymateriaali
IN2015KN00666A (fi)
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
MX354068B (es) Construcciones de tejido bio-diseñadas por ingenieria y metodos para la produccion y uso de las mismas.
FI20115054A (fi) Menetelmä lujuuden ja retention parantamiseksi ja paperituote
SG171542A1 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
MX363493B (es) Composiciones para cultivo celular y metodos para la produccion de polipetidos.
MY168166A (en) Polymer and Composition Including Same, and Adhesive Composition
RU2011135537A (ru) Штамм enterococcus hirae, используемый при производстве кисломолочных продуктов
EA201301264A1 (ru) Способ получения неорганического материала в виде частиц
AU2011278339A8 (en) Polymer composite material with biocide functionality
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
PH12014502834A1 (en) Pharmaceutical form for extended release of active substances
GB2496356A (en) Pharmaceutical composition and method of inhibiting of production or amplifying elimination of P24 protein
EP2573167A4 (en) METHOD FOR THE PRODUCTION OF AUTOLOGOUS SKIN OR DRESSINGS BY CULTURING KERATINOCYTES AND AUTOLOGOUS FIBROBLASTS WITH AUTOLOGOUS SERUM TO GENERATE SKIN
FI20115328A (fi) Uusia kutinaaseja, niiden tuottaminen ja käytöt
LT2013016A (lt) Aktyvuotos-potencijuotos formos antikūno poveikio padidinimo būdas
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
BR112015005884A2 (pt) processos para degradação de um material celulósico, para produção de um produto da fermentação, e de fermentação de um material celulósico, composição, e, formulação de caldo inteiro ou composição de cultura de células
UA113977C2 (xx) Фармацевтична композиція з покращеною стабільністю
TW200712129A (en) Silicone material having outstanding viscosity stability
BRPI0907486A2 (pt) Triazolpiridazinas como inibidores de par1, sua produção e uso como medicamentos
EA201590782A1 (ru) Оксирановые амины
AU2012350258A8 (en) Mutated lentiviral ENV proteins and their use as drugs
BR112013012687A2 (pt) "processo para produzir um material compósito, material compósito, e, uso de um material compósito."

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: UPM-KYMMENE CORPORATION

Free format text: UPM-KYMMENE CORPORATION

FG Patent granted

Ref document number: 123988

Country of ref document: FI

Kind code of ref document: B